USANA Health Sciences, Inc. (USNA) Social Stream



USANA Health Sciences, Inc. (USNA): $61.58

0.44 (+0.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

USANA HEALTH SCIENCES INC (USNA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering USANA HEALTH SCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 1 $90 $90 $90 $61.06 47.4%
2022-02-10 2 $78 $78 $78 $61.06 27.74%
2022-04-14 2 $86 $78 $82 $61.06 34.29%
2022-04-27 2 $78 $76 $77 $61.06 26.11%
2022-07-12 2 $58 $53 $55.5 $61.06 -9.11%
2022-07-28 2 $57 $53 $55 $61.06 -9.92%
2022-10-27 1 $49 $49 $49 $61.06 -19.75%
2023-02-13 1 $52.5 $52.5 $52.5 $61.06 -14.02%

Price Target Last Issued October 27, 2022

The Trend in the Analyst Price Target


USNA's average price target has moved down $37.5 over the prior 34 months.

Over the past 44 weeks, USNA's average upside potential has been -13.58%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-27 2 78 76 77.0 75.93 1.41%
2022-07-12 2 58 53 55.5 67.46 -17.73%
2022-07-28 1 57 57 57.0 70.16 -18.76%
2022-07-28 2 57 57 57.0 70.16 -18.76%
2022-07-28 1 57 53 55.0 70.16 -21.61%

USNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


Over the past 44 weeks, USNA's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, USANA HEALTH SCIENCES INC's number of analysts covering the stock is greater than 16.55% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, USANA HEALTH SCIENCES INC's variance in analysts' estimates is lower than 79.26% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, USANA HEALTH SCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 115.94% of them.
  • USNA has a greater average analyst price target than 765.76% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to USANA HEALTH SCIENCES INC are LNTH, RIOT, and HSKA.

What is the outlook for USNA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7725 seconds.